Boris L. Zhuikov

Boris L. Zhuikov

Auto-generated profile, based on publicly available information

Boris L. Zhuikov

Russian Academy of Sciences

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2011 in Radiochemistry
Verified
Journal Article
Closed access
PDF file
BZB. L. Zhuikov
B. L. Zhuikov
SKS. N. Kalmykov
S. N. Kalmykov
SES. V. Ermolaev
S. V. Ermolaev
RAR. A. Aliev
R. A. Aliev
VKV. M. Kokhanyuk
V. M. Kokhanyuk
BMB. F. Myasoedov
B. F. Myasoedov
The possibility of producing 225Ac and 223Ra by irradiation of natural 232Th with medium-energy protons was examined. Thorium foils were irradiated with 90-, 110-, and 135-MeV protons at the accelerator of the Institute for Nuclear Research, Russian Academy of Sciences, in Troitsk (Moscow oblast). The cumulative production cross sections for 225Ac were 6.7 ± 0.9, 9.8 ± 1.9, and 13.9 ± 1.5 mb, and for 227Th (223Ra precursor), 43 ± 5, 37 ± 6, and 35 ± 4 mb, respectively. Based on the experimental data and theoretical calculations, the possible yields of 225Ac and 223Ra in irradiation of thick thorium targets at various accelerators were determined. An efficient procedure was suggested for isolating the products from the irradiated targets: 225Ac, by liquid extraction and extraction chromatography, and 223Ra, by sublimation from a thorium-lanthanum melt followed by thermochromatographic separation in metallic titanium columns and extraction-chromatographic isolation of radium. The procedure allows production of large (units of curies) amounts of radiochemically pure 225Ac and 223Ra, which is promising for wide use of these radionuclides in nuclear medicine.

1 February 2014 in Applied Radiation and Isotopes
Verified
Journal Article
Open access
BZB.L. Zhuikov
B.L. Zhuikov
We present a review of reactor and accelerator centers in Russia that produce medical isotopes, the majority of which are exported. In the near future, we anticipate increased isotope production for use in nuclear medicine in Russia. The existing linear accelerator at the Institute for Nuclear Research (Moscow-Troitsk) and several prospective installations are considered to be particularly capable of providing mass production of radionuclides that can substitute, to a certain extent, for the traditional medical isotopes.

1 August 2015 in Journal of Radioanalytical and Nuclear Chemistry
Verified
Journal Article
Closed access
PDF file
VOV. Ostapenko
V. Ostapenko
AVAleksandr Vasiliev
Aleksandr Vasiliev
ELE. Lapshina
E. Lapshina
SES. Ermolaev
S. Ermolaev
RAR. Aliev
R. Aliev
SKS. Kalmykov
S. Kalmykov

6 February 2019 in Brain and Behavior
Verified
Journal Article
Open access
PDF file
NKNikolay A. Kostenikov
Nikolay A. Kostenikov
BZBoris L. Zhuikov
Boris L. Zhuikov
VCValeriy M. Chudakov
Valeriy M. Chudakov
YIYuriy R. Iliuschenko
Yuriy R. Iliuschenko
SSSergey V. Shatik
Sergey V. Shatik
ASAndrey A. Stanzhevskiy
Andrey A. Stanzhevskiy
Introduction: The applicability of “Rubidium Chloride, 82 Rb from Generator” radiopharmaceutical for brain tumors (BT) diagnostics is demonstrated on the basis of the application experience of the radiopharmaceutical in neurooncology. Experimental: A total of 21 patients with various brain tumors and nonneoplastic abnormal brain masses were investigated. Results and Discussions: The results of the imaging and differential diagnostics of malignant and benign tumors, nonneoplastic abnormal brain masses and lesions revealed the prevalence of high uptake of the radiopharmaceutical in the malignant tumors in comparison with benign glioma and arteriovenous malformations in which 82 Rb‐chloride accumulates in the vascular phase but does not linger further. The ultra‐short half‐life of radionuclide 82 Rb (76 s) along with a low absorbed radiation dose with 82 Rb‐chloride by intravenous administration create a new possibility of successive use of two or more radiopharmaceuticals for the examination of the same patient. For instance, PET examination with 18 F‐FDG, 11 C‐methionine, 11 C‐choline, or any other radiopharmaceutical can be carried out in just 7–15 min. after 82 Rb‐chloride injection. Conclusion: Research demonstrated an effectiveness of 82 Rb‐chloride application as a diagnostic agent in neurooncology. A method of dosing and administration of the generator‐produced radiopharmaceutical has been worked out. It is possible to do up to 600 PET sessions using one Russian 82 Rb generator GR‐01. The generator is proved to be reliable and easy to use. The interest in 82 Rb‐chloride as a tumor‐seeking radiopharmaceutical rose due to the active application of the modern devices PET/CT in the routine clinical practice.

1 September 2014 in Radiochemistry
Verified
Journal Article
Closed access
PDF file
VCV. M. Chudakov
V. M. Chudakov
BZB. L. Zhuikov
B. L. Zhuikov
SES. V. Ermolaev
S. V. Ermolaev
VKV. M. Kokhanyuk
V. M. Kokhanyuk
MMM. I. Mostova
M. I. Mostova
LTL. A. Tyutin
L. A. Tyutin
Characteristics of the developed 82Rb medical generator intended for the production of Rubidium Chloride, 82Rb from Generator radiopharmaceutical for positron emission tomography (PET) are examined. The results of laboratory tests and clinical trials are presented. The influence of thermal sterilization on the ionexchange characteristics of the sorbent based on hydrous tin(IV) oxide is studied. The possibility of radiation “self-sterilization” of the generator column and of the maintenance of aseptic conditions in it throughout the generator operation life is assessed. In the course of operation of one generator, it is possible to obtain up to 19 L of a sterile and apyrogenic solution of the radiopharmaceutical with permissible content of radioactive and stable impurities. The efficiency of the 82Rb elution from the sorbent at different eluent flow rates is determined. The efficiency of using the generator in PET investigations in cardiology and oncology is demonstrated.

1 September 2019 in Radiochemistry
Verified
Journal Article
Closed access
PDF file
BZB. L. Zhuikov
B. L. Zhuikov
A model was suggested for calculating the enthalpy of adsorption or deposition temperature in thermochromatography of ultramicroamounts of substances from the thermodynamic data. In this model, the...